ALPROLIX, created in 2011 (Sweden), from 28 sister brands and 4958 competing brands. ALPROLIX is owned by Swedish Orphan Bio, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Swedish Orphan Bio is SE0000872095. ALPROLIX belongs to the Drug Manufacturers business sector.